Berry Genomics

Products

Category

Product

Brand

Description

The Chinese Market for DNA Sequencing (BIO152C)

NextSeq CN500 Gene Sequencer		The NextSeq CN500 Gene Sequencer is a benchtop NGS system co-developed by Illumina and Berry Genomics specifically for the Chinese clinical market. The system integrates Illumina’s sequencing-by-synthesis (SBS) technology with local software and workflow modifications to accommodate various applications, comprising non-invasive prenatal testing (NIPT) and oncology panel sequencing.
BerrySeq NIPT		This was co-developed by Illumina and Berry Genomics and is used for screening fetal chromosomal aneuploidies using maternal blood, leveraging next-generation sequencing for high accuracy and safety. It was among China’s first CFDA-approved NIPT platforms and has been widely adopted across hospitals.

This information is available for BCC Research members only.

Already a Member? Sign In Become a Member

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment